Dog Mast Cell Tumors: Welfare Through Diagnosis and Treatment

Mast cell tumors are among the most common skin cancers in dogs. Early detection and appropriate treatment are key to preserving quality of life.

Key Facts

Mast cell tumors (MCTs) account for approximately 20% of all skin tumors in dogs
They can vary enormously in behaviour — some are benign, others highly aggressive
Grading (low, intermediate, high) determines prognosis and treatment approach
Boxers, Bulldogs, Labrador Retrievers, and Golden Retrievers are predisposed breeds
Treatment may include surgery, radiation, chemotherapy, or targeted therapies (toceranib)
Early surgical removal of low-grade tumors often results in cure

Welfare Considerations

Dogs with mast cell tumors may experience local discomfort from the tumor itself, as well as systemic effects from mast cell degranulation (histamine release causing vomiting, ulcers). Treatment can involve surgery with significant wound management, and chemotherapy may have side effects including fatigue and nausea. Welfare-focused oncology prioritises pain management, quality of life assessment, and honest conversations with owners about treatment goals. Not all dogs benefit from aggressive treatment — palliative care is a valid and compassionate choice.

What You Can Do

Check your dog regularly for new lumps or skin changes — early detection matters
Have any new skin mass evaluated by a vet promptly, not assumed to be benign
Request fine needle aspiration for any new lump — it is quick and minimally invasive
Discuss quality of life expectations honestly with your oncologist before starting treatment
Ask about palliative care options if curative treatment is not feasible